Compare Sundaram Multi. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 2.32%
- Poor long term growth as Operating profit has grown by an annual rate 19.28% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.61
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
Latest dividend: 0.01 per share ex-dividend date: Sep-23-2014
Risk Adjusted Returns v/s 
Returns Beta
News

Sundaram Multi Pap Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
Sundaram Multi Pap Ltd has been downgraded from a Sell to a Strong Sell rating as of 15 June 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite recent positive quarterly financial results, the company’s long-term performance and valuation metrics continue to lag behind industry benchmarks, prompting a reassessment of its investment appeal.
Read full news article
Sundaram Multi Pap Ltd Upgraded from Strong Sell to Sell on Technical Improvements
Sundaram Multi Pap Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 10 June 2026, driven primarily by a shift in technical indicators. Despite this improvement, the company continues to face challenges in long-term fundamentals and financial strength, resulting in a cautious outlook for investors.
Read full news article
Sundaram Multi Pap Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
Sundaram Multi Pap Ltd has been downgraded from a Sell to a Strong Sell rating as of 5 June 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some recent positive quarterly financial results, the company continues to underperform its benchmarks and peers, prompting a reassessment of its investment appeal across quality, valuation, financial trend, and technical parameters.
Read full news article Announcements 
Sundaram Multi Pap Limited - Amalgamation / Merger
14-Nov-2019 | Source : NSESundaram Multi Pap Limited has informed the Exchange about Amalgamation/Merger . Disclosure of Voting Results of the Meeting Secured Creditors of the Company convened & held on November 12, 2019 as per the directions issued by National Company Law Tribunal, Mumbai Bench
Sundaram Multi Pap Limited - Amalgamation / Merger
13-Nov-2019 | Source : NSESundaram Multi Pap Limited has informed the Exchange about Amalgamation/Merger .
Sundaram Multi Pap Limited - Shareholders meeting
09-Oct-2019 | Source : NSESundaram Multi Pap Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on November 12, 2019.
Corporate Actions 
No Upcoming Board Meetings
Sundaram Multi Pap Ltd has declared 1% dividend, ex-date: 23 Sep 14
No Splits history available
Sundaram Multi Pap Ltd has announced 2:1 bonus issue, ex-date: 13 Apr 12
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
2.2192
Held by 0 Schemes
Held by 0 FIIs
Yash Raichand Shah (9.94%)
Vyoman India Private Limited (2.87%)
60.62%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 11.85% vs -2.12% in Mar 2025
YoY Growth in quarter ended Mar 2026 is 237.65% vs -454.17% in Mar 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.41% vs 2.83% in Sep 2024
Growth in half year ended Sep 2025 is 124.68% vs 50.31% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 5.67% vs 1.44% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 147.07% vs 19.74% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 7.60% vs 0.30% in Mar 2025
YoY Growth in year ended Mar 2026 is 162.11% vs -0.79% in Mar 2025






